HSBC Holdings
KRYS icon

HSBC Holdings’s Krystal Biotech KRYS Stock Holding History

HSBC Holdings’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65M Buy
+9,598
New +$2.87M ﹤0.01% 1334
2025
Q2 		– Sell
-2,875
Closed -$508K – 3134
2025
Q1 		$508K Sell
2,875
-1,644
-36% -$277K ﹤0.01% 2074
2024
Q4 		$718K Buy
4,519
+2,988
+195% +$530K ﹤0.01% 1971
2024
Q3 		$278K Buy
+1,531
New +$295K ﹤0.01% 2405

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HSBC Holdings's KRYS Position: Q2 2026 in Review

HSBC Holdings opened a new position in Krystal Biotech (KRYS) in Q2 2026: 9,598 shares worth $3.65M. The stake represents ﹤0.01% of the portfolio and ranks #1334 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in KRYS as recently as Q1 2025.

HSBC Holdings first reported a position in KRYS in Q3 2024 and has held it in 4 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • HSBC Holdings held 9,598 shares of Krystal Biotech worth $3.65M as of Q2 2026.
  • Krystal Biotech was a new HSBC Holdings position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1334 holding.
  • HSBC Holdings first reported a position in Krystal Biotech in Q3 2024 and has held it in 4 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.